AU3888597A - Oral contraceptive - Google Patents

Oral contraceptive

Info

Publication number
AU3888597A
AU3888597A AU38885/97A AU3888597A AU3888597A AU 3888597 A AU3888597 A AU 3888597A AU 38885/97 A AU38885/97 A AU 38885/97A AU 3888597 A AU3888597 A AU 3888597A AU 3888597 A AU3888597 A AU 3888597A
Authority
AU
Australia
Prior art keywords
oral contraceptive
contraceptive
oral
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU38885/97A
Other languages
English (en)
Inventor
Michael Jay Gast
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth LLC
Original Assignee
American Home Products Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Home Products Corp filed Critical American Home Products Corp
Publication of AU3888597A publication Critical patent/AU3888597A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU38885/97A 1996-07-26 1997-07-23 Oral contraceptive Abandoned AU3888597A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US69043996A 1996-07-26 1996-07-26
US08690439 1996-07-26
PCT/US1997/012785 WO1998004246A2 (fr) 1996-07-26 1997-07-23 Contraceptif oral

Publications (1)

Publication Number Publication Date
AU3888597A true AU3888597A (en) 1998-02-20

Family

ID=24772470

Family Applications (1)

Application Number Title Priority Date Filing Date
AU38885/97A Abandoned AU3888597A (en) 1996-07-26 1997-07-23 Oral contraceptive

Country Status (2)

Country Link
AU (1) AU3888597A (fr)
WO (1) WO1998004246A2 (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4344462C2 (de) 1993-12-22 1996-02-01 Schering Ag Zusammensetzung für die Empfängnisverhütung
FR2754179B1 (fr) 1996-10-08 1998-12-24 Theramex Nouvelle composition hormononale et son utilisation
US5898032A (en) 1997-06-23 1999-04-27 Medical College Of Hampton Roads Ultra low dose oral contraceptives with less menstrual bleeding and sustained efficacy
JP2002534469A (ja) * 1999-01-18 2002-10-15 ノボ ノルディスク アクティーゼルスカブ エストロゲン及びデルタ−ゴナジエン−２１−オール−３，２０−ジオンの使用
AU2092300A (en) * 1999-01-18 2000-08-01 Novo Nordisk A/S Use of estrogens and delta-gonadien-21-ol-3,20-diones in the treatment or prophylaxis of cerebral degenerative disorders
EP1143979A1 (fr) 1999-01-18 2001-10-17 Novo Nordisk A/S Utilisation d'oestrogenes et de delta-gonadiene-21-ol-3,20-diones dans le traitement des diabetes insulino-dependant et non insulino-dependant
FR2801218B1 (fr) * 1999-11-23 2001-12-28 Hoechst Marion Roussel Inc Compositions pharmaceutiques comprenant de la trimegestone, leurs procedes de preparation ainsi que le conditionnement primaire les renfermant
PL213122B1 (pl) 2001-12-05 2013-01-31 Duramed Pharmaceuticals Zestaw i preparat zawierajacy estrogen i progestagen
US7772219B2 (en) 2003-05-02 2010-08-10 Teva Women's Health, Inc. Methods of hormonal treatment utilizing extended cycle contraceptive regimens
CN101001631B (zh) 2003-07-16 2014-08-06 特卫华妇女健康有限公司 利用连续给予雌激素的避孕方案的激素治疗方法
US20070111975A1 (en) 2004-10-07 2007-05-17 Duramed Pharmaceuticals, Inc. Methods of Hormonal Treatment Utilizing Ascending-Dose Extended Cycle Regimens
BRPI0516247A (pt) * 2004-10-07 2008-08-26 Duramed Pharmaceuticals Inc métodos de tratamento hormonal, utilizando regimes de ciclo prolongado de dose crescente
AU2006271920A1 (en) * 2005-07-20 2007-01-25 Grunenthal Gmbh Oral contraception with trimegestone
US8153616B2 (en) 2005-10-17 2012-04-10 Bayer Pharma Aktiengesellschaft Combination preparation for oral contraception and oral therapy of dysfunctional uterine bleeding containing estradiol valerate and dienogest and method of using same
US8617597B2 (en) 2006-07-06 2013-12-31 Bayer Intellectual Property Gmbh Pharmaceutical composition containing a tetrahydrofolic acid
EP1930010A1 (fr) 2006-10-20 2008-06-11 Bayer Schering Pharma Aktiengesellschaft Utilisation de valvérate d'estradiol ou de 17ß-estradiol combiné à du dienogest pour traiter par voie orale la récupération et/ou l'augmentation de la libido féminine

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4313926A1 (de) * 1993-04-28 1994-11-03 Jenapharm Gmbh Pharmazeutisches Mehrphasenpräparat zur hormonalen Kontrazeption
NL9301562A (nl) * 1993-09-09 1995-04-03 Saturnus Ag Preparaat voor substitutietherapie.

Also Published As

Publication number Publication date
WO1998004246A2 (fr) 1998-02-05
WO1998004246A3 (fr) 2002-09-26

Similar Documents

Publication Publication Date Title
AU9187598A (en) Oral preparation
AU3214797A (en) Engineering oral tissues
AU5428096A (en) Oral 2-methyl-thieno-benzodiazepine formulation
AU4928396A (en) Oral compositions
AU5136998A (en) Medicinal composition
AU2654299A (en) Wheelchair
AU3888597A (en) Oral contraceptive
AU7265596A (en) Probiotically acting formulations
AU3154395A (en) Contraceptive vaccine
HUP9904345A3 (en) Oral contraceptive
AU2769595A (en) Contraceptive vaccine
AU3460897A (en) Medicinal compositions
AU8995998A (en) Pacifier
AU4756996A (en) Oral compositions
AU3961697A (en) Oral contraceptive
AU3709095A (en) Mini-beauty case for oral hygiene
AU2815897A (en) Oral contraceptive
AU8858798A (en) Pacifier
AU2926897A (en) Oral contraceptive
AU2746097A (en) Oral contraceptive
AU2926797A (en) Oral contraceptive
AU2926997A (en) Oral contraceptive
AU6092798A (en) Condom
AU8877998A (en) Oral vaccine
AU1871097A (en) A condom